E
Eugene Maxwell
Researcher at Merck & Co.
Publications - 6
Citations - 619
Eugene Maxwell is an academic researcher from Merck & Co.. The author has contributed to research in topics: Receptor & Protein kinase B. The author has an hindex of 5, co-authored 6 publications receiving 585 citations.
Papers
More filters
Journal ArticleDOI
Restoring Methicillin-Resistant Staphylococcus aureus Susceptibility to β-Lactam Antibiotics
Christopher M. Tan,Alex G. Therien,Jun Lu,Sang Ho Lee,Alexandre Caron,Charles Gill,Christian Lebeau-Jacob,Liliana L. Benton-Perdomo,João M. Monteiro,Pedro M. Pereira,Nathaniel L. Elsen,Jin Wu,Kathleen Deschamps,Mihai Petcu,Simon Wong,Etienne Daigneault,Susanne Kramer,Lianzhu Liang,Eugene Maxwell,David Claveau,John P. Vaillancourt,Kathryn Skorey,John Tam,Hao Wang,Timothy C. Meredith,Susan Sillaots,Lisa Wang-Jarantow,Yeeman K. Ramtohul,Eric Langlois,John C. Reid,Gopal Parthasarathy,Sujata Sharma,Anastasia Baryshnikova,Kevin J. Lumb,Mariana G. Pinho,Stephen M. Soisson,Terry Roemer +36 more
TL;DR: A Staphylococcus aureus antisense knockdown strategy is adapted to genetically identify the cell division Z ring components—FtsA, FtsZ, and FtsW—as β-lactam susceptibility determinants of methicillin-resistant S. aureUS to support a target-based approach to develop synergistic drug combinations to combat MRSA with improved efficacy and reduced potential for drug resistance.
Journal Article
Biochemical Characterization of the Binding of Echistatin to Integrin αvβ3 Receptor
C. Chandra Kumar,Christine Prorock Rogers Huiming-Nie,Mike Malkowski,Eugene Maxwell,Joseph J. Catino,Lydia Armstrong +5 more
TL;DR: It is demonstrated that echistatin binding to α vβ 3 is of high affinity and irreversible similar to vitronectin and provides an alternate ligand for high-throughput screening for α v β 3 antagonists.
Journal ArticleDOI
The Farnesyl Transferase Inhibitor SCH 66336 Induces a G2 → M or G1 Pause in Sensitive Human Tumor Cell Lines
Hena R. Ashar,Linda James,Kimberly Gray,Donna Carr,Marnie McGuirk,Eugene Maxwell,Stuart Black,Lydia Armstrong,Doll Ronald J,Taveras Arthur G,W. Robert Bishop,Paul Kirschmeier +11 more
TL;DR: Experiments show that SCH 66336 altered the cell cycle distribution of sensitive human tumor cells in two distinct ways, and suggest that cell cycle effects, either G(1) or G(2)-->M accumulation, and p53 status are important for mediating the effects of FTIs on tumor cells.
Journal Article
Neutralizing Anti-Insulin-like Growth Factor Receptor 1 Antibodies Inhibit Receptor Function and Induce Receptor Degradation in Tumor Cells
TL;DR: neutralizing antibodies against IGFR1 represent a valid approach to inhibit growth of tumor cells and inhibited the growth of MCF7 cells in soft agar.
Journal Article
Adenoviral-mediated expression of a kinase-dead mutant of Akt induces apoptosis selectively in tumor cells and suppresses tumor growth in mice.
Amanda Jetzt,John A. Howe,Mark T. Horn,Eugene Maxwell,Zhizhang Yin,Duane E. Johnson,C. Chandra Kumar +6 more
TL;DR: In vitro proliferation of human and mouse tumor cells expressing high levels of activated/phosphorylated Akt was inhibited by both Akt-DN and p53, in comparison with control viruses expressing beta-galactosidase and empty virus.